KfW

CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

Everphone GmbH, founded in 2016 and based in Berlin, Germany, specializes in the rental of smartphones and tablets for employees. The company provides a comprehensive solution that includes device procurement, logistics, and mobile device management, allowing organizations to efficiently manage their mobile device needs. Everphone's proprietary software platform facilitates direct interaction with employees through various digital channels, enabling them to select and borrow devices on a rental basis. Additionally, the company offers services for the repair, replacement, and exchange of old or damaged devices, thereby supporting businesses in maintaining a seamless mobile experience without heavily taxing their internal IT resources.

Vectoflow GmbH, founded in 2014 and based in Gilching, Germany, specializes in the manufacture of fluid-dynamic metrology devices designed to assess fluid flow and dynamics. The company offers a range of standardized and customizable flow measurement technologies that accurately measure static and total pressure, velocity, and angle of attack. These devices are tailored to meet specific customer requirements regarding geometry, size, and material, making them suitable for various applications in motorsports, aviation, turbine machine development, and research. Vectoflow's manufacturing process enhances the robustness of its probes, ensuring reliable performance even in challenging environmental conditions, thus enabling clients to obtain durable solutions for their fluid measurement needs.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assets into a separate company that began operating on 1 January 2016.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

Productsup GmbH, founded in 2010 and based in Simmelsdorf, Germany, operates a cloud-based product-to-consumer (P2C) platform that facilitates comprehensive product data management. The platform enables manufacturers, brands, service providers, and marketplaces to streamline their commerce processes. Productsup offers solutions such as feed management, marketplace experience, social commerce, product content syndication, and vendor onboarding. It effectively manages and processes over two trillion products monthly for more than 900 brands, including notable names like IKEA and Sephora. By structuring, analyzing, and optimizing product data, the platform allows clients to create customized feeds for various shopping and marketing channels, enhancing their online visibility and overall performance.

Cleverciti, founded in 2012 by Thomas Hohenacker, specializes in smart parking technologies aimed at optimizing outdoor parking operations. The company offers an intelligent, easy-to-deploy solution that enhances parking management by identifying available parking spaces and guiding drivers to them, thereby reducing traffic congestion and vehicle emissions. Cleverciti's platform uniquely integrates intelligent parking detection with driver communication, enabling organizations to leverage data for various operational needs, including marketing and customer service. With a presence in multiple sectors such as retail, smart cities, healthcare, and transportation, Cleverciti positions itself as a leader in the smart parking industry. The company operates globally, with headquarters in Munich and Chicago, and provides comprehensive sales, professional services, and customer support to meet the needs of its clients.

Kraftwerk is a renewable energy company based in Germany, founded in 2016. The company specializes in developing innovative fuel cell technology that directly converts various fuels, including natural gas, liquefied gas, gasoline, and kerosene, into electricity. This technology enables the creation of lightweight and highly efficient energy sources suitable for a wide range of applications. Kraftwerk's fuel cells can be utilized in transportation, including e-bikes, passenger vehicles, light commercial vehicles, motorhome RVs, and medium-duty trucks. Additionally, they are applicable in stationary and portable systems, serving small to mid-size applications such as portable power, emergency power, waste-to-energy solutions, and IoT charging. The company aims to advance clean energy solutions across various sectors.

CureVac is a clinical-stage biopharmaceutical company based in Germany, focused on developing vaccines and therapies utilizing messenger RNA (mRNA). Founded in 2000, the company’s innovative approach involves using mRNA as a data carrier to instruct the body to produce proteins that can combat various diseases. CureVac's pipeline includes novel mRNA-based cancer immunotherapies, prophylactic vaccines for infectious diseases, and molecular therapies aimed at enhancing the body’s production of therapeutic proteins. Its most advanced candidate, CV9104, is currently in Phase IIb clinical trials for prostate cancer treatment. Additionally, CureVac has collaborated with GSK to create second-generation vaccines for seasonal influenza and COVID-19, as well as an avian influenza vaccine, while exploring other mRNA vaccine applications in oncology and various therapeutic areas.

Adidas is a prominent global sports brand founded in 1949 and headquartered in Herzogenaurach, Germany. The company designs, develops, produces, and markets a wide range of athletic and leisure products, including footwear, apparel, accessories, and sports equipment. Its offerings cater to various consumer needs, from competitive athletics to casual fashion, allowing Adidas to address diverse market opportunities and reduce exposure to market risks. The brand is recognized for its commitment to innovation, performance, and sustainability, symbolized by its iconic three stripes. With a broad product portfolio, Adidas focuses on key segments such as Football, Running, Training, Basketball, and Originals. The company distributes its products in over 160 countries through an extensive network of retail stores, franchise outlets, wholesale partners, and e-commerce platforms. Through its dedication to quality and design, Adidas continues to inspire athletes and consumers worldwide.

OMEICOS Therapeutics GmbH is a Berlin-based company founded in 2013 that specializes in developing novel therapeutics for cardiovascular diseases and other health conditions. The company focuses on small molecule therapies derived from natural metabolites of omega-3 fatty acids, which exhibit a unique mode of action. These substances activate an endogenous cardio-protective signaling pathway, providing both anti-arrhythmic effects and curative benefits by stabilizing heart rhythm and preventing electrical and structural remodeling of the heart. In addition to cardiovascular applications, OMEICOS also explores treatments for inflammatory and ophthalmic diseases, aiming to deliver safe and effective therapeutic options for various medical indications.

VEACT GmbH, founded in 2010 and headquartered in Munich, Germany, specializes in providing software solutions for after-sales marketing in the automotive industry. The company develops a platform that digitizes marketing processes, leveraging self-learning technology and extensive automotive expertise. By integrating various data sources, including invoices, service histories, and customer surveys, VEACT creates comprehensive customer profiles that facilitate predictive customer intelligence. This approach allows automotive dealerships and manufacturers to enhance the efficiency of their marketing and sales operations, ultimately resulting in reduced costs, improved customer loyalty, and increased revenue.

Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, founded in 2010. It specializes in developing innovative solutions for the treatment and management of glaucoma, a prevalent eye disease. The company's flagship product, Eyemate, is an implantable micro sensor designed for continuous intraocular pressure measurement. This biocompatible device allows for 24-hour monitoring without compromising the patient's vision or overall well-being. By integrating advanced medical technology with information technology, Implandata aims to enhance the efficiency of glaucoma therapy, benefiting patients, their families, and caregivers. The company's focus on addressing unmet needs in glaucoma care positions it as a significant player in the ophthalmic medical device sector.

​​​Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.

BigRep is a global leader in large-format FFF 3D printing, aiming to enhance productivity and creativity through accessible additive manufacturing solutions. Founded in 2014 and headquartered in Berlin, with offices in Boston and Singapore, the company provides industrial 3D printers tailored for large-scale production. By facilitating a faster transition from prototyping to production, BigRep enables engineers, designers, and manufacturers—ranging from startups to established enterprises—to expedite their product development cycles. The company collaborates with strategic partners, including BASF and Bosch Rexroth, to offer comprehensive additive manufacturing solutions that include advanced printers, software, and materials. BigRep's innovations are designed to reshape the manufacturing landscape by making it more individualized, creative, and cost-effective.

amcure is a privately held, clinical-stage company developing peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. Established in 2012, amcure GmbH is a spin-off from the Karlsruhe Institute of Technology (KIT) and is supported by a grant from the German Federal Ministry of Education and Research. amcure leverages its in-depth knowledge of CD44 target biology to develop a novel therapeutic approach to treat metastatic squamous tumors. In cancer, blocking the extracellular target CD44v6 has a beneficial effect on several relevant receptor tyrosine kinase pathways. Their first-in-class CD44v6-inhibitor AMC303 entered clinical development in solid tumors in Q4 2016.

Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug candidates for the treatment of hearing loss. Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells by cellular regeneration originating from supporting cells. ASpherecousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, these therapies will have the potential to treat the age-related decrease in hearing capacity.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

fromAtoB GmbH operates a travel search engine that facilitates the comparison and integration of various modes of transportation across Europe, North America, and internationally. Founded in 2008 and based in Munich, Germany, the company provides users with access to a wide range of transportation options, including trains, flights, rideshares, long-distance buses, taxis, rental cars, and public transportation. Its platform serves as a multimodal journey planner, allowing users to search for and compare travel deals while also enabling secure bookings with different transport providers.

​​​Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.

Trinckle is a Berlin-based company specializing in software solutions for additive manufacturing. Its primary product, paramate, automates design processes and offers a platform for advanced product configuration. This technology allows for customer-specific adaptations across various applications, including tailored prostheses, optimized industrial components, low-volume jigs and fixtures, and personalized lifestyle products. By leveraging industrial machines and automated processes, Trinckle's platform streamlines complex design tasks, enabling businesses to efficiently transform digital designs into 3D printed products. This approach not only enhances customization but also makes 3D printing services more accessible and cost-effective for a diverse range of industries.

Cleverciti, founded in 2012 by Thomas Hohenacker, specializes in smart parking technologies aimed at optimizing outdoor parking operations. The company offers an intelligent, easy-to-deploy solution that enhances parking management by identifying available parking spaces and guiding drivers to them, thereby reducing traffic congestion and vehicle emissions. Cleverciti's platform uniquely integrates intelligent parking detection with driver communication, enabling organizations to leverage data for various operational needs, including marketing and customer service. With a presence in multiple sectors such as retail, smart cities, healthcare, and transportation, Cleverciti positions itself as a leader in the smart parking industry. The company operates globally, with headquarters in Munich and Chicago, and provides comprehensive sales, professional services, and customer support to meet the needs of its clients.

BigRep is a global leader in large-format FFF 3D printing, aiming to enhance productivity and creativity through accessible additive manufacturing solutions. Founded in 2014 and headquartered in Berlin, with offices in Boston and Singapore, the company provides industrial 3D printers tailored for large-scale production. By facilitating a faster transition from prototyping to production, BigRep enables engineers, designers, and manufacturers—ranging from startups to established enterprises—to expedite their product development cycles. The company collaborates with strategic partners, including BASF and Bosch Rexroth, to offer comprehensive additive manufacturing solutions that include advanced printers, software, and materials. BigRep's innovations are designed to reshape the manufacturing landscape by making it more individualized, creative, and cost-effective.

Aquila biolabs GmbH is a German technology company established in 2014 and located in Baesweiler, Germany. It specializes in the development of innovative laboratory devices aimed at optimizing bioprocesses in bioreactors and incubation shakers. The company's product lineup includes the Cell Growth Quantifier (CGQ), Cell Growth Quantifier BIOR (CGQ BIOR), and the Liquid Injection System (LIS). These solutions feature smart sensors and data analytics software that facilitate real-time, non-invasive monitoring of cell growth in shake flasks. By providing automated and process-optimizing analysis, Aquila biolabs enables research scientists to obtain actionable insights during the cultivation of therapeutic products in various experimental settings.

Sicoya GmbH, founded in January 2015 as a spin-off from TU Berlin, specializes in designing, packaging, and selling silicon photonics-based application specific photonic integrated circuits (ASPICs). The company offers its ASPICs as bare dies or packaged chips and has developed miniature silicon photonics modulators that combine traditional CMOS processing with optical components. Since entering the market for data center interconnects in 2017, Sicoya has introduced a 100G transceiver chip that integrates both electronics and optics on a single chip. The company has received initial purchase orders for qualification units and is preparing customer samples for major data center players. Sicoya aims to enhance internet connectivity in next-generation data centers, facilitating the development of new internet services through its power-efficient and scalable optical transceiver solutions.

VEACT GmbH, founded in 2010 and headquartered in Munich, Germany, specializes in providing software solutions for after-sales marketing in the automotive industry. The company develops a platform that digitizes marketing processes, leveraging self-learning technology and extensive automotive expertise. By integrating various data sources, including invoices, service histories, and customer surveys, VEACT creates comprehensive customer profiles that facilitate predictive customer intelligence. This approach allows automotive dealerships and manufacturers to enhance the efficiency of their marketing and sales operations, ultimately resulting in reduced costs, improved customer loyalty, and increased revenue.

Datapine GmbH, founded in 2012 and based in Berlin, Germany, specializes in developing data visualization and business intelligence (BI) software as a service (SaaS). Its platform offers a range of tools for business analysis, data visualization, and reporting, making it accessible to both technical and non-technical users. This enterprise-grade solution facilitates the merging of diverse data sets without the need for extensive database restructuring, enabling users to explore and visualize data seamlessly. Datapine serves a variety of sectors, including energy, healthcare, financial services, logistics, and retail, providing not only BI tools but also consulting and coaching services. The company aims to lead the innovation in the BI market for small and medium-sized enterprises, helping organizations make informed decisions by uncovering insights and trends within their data.

Minodes GmbH, founded in 2013 and based in Berlin, Germany, provides a platform that enhances the performance of offline retail stores. The company's services focus on consumer analytics, allowing retailers to gain insights into factors affecting customer behavior and in-store revenue. By utilizing this platform, retailers can optimize their operations, store layouts, and marketing strategies to cater to various customer segments, from first-time visitors to loyal customers. Minodes also offers tools for launching location-based mobile marketing campaigns, enabling retailers to drive store traffic and engage consumers effectively. As of May 2017, Minodes operates as a subsidiary of Telefónica Germany NEXT GmbH.

OMEICOS Therapeutics GmbH is a Berlin-based company founded in 2013 that specializes in developing novel therapeutics for cardiovascular diseases and other health conditions. The company focuses on small molecule therapies derived from natural metabolites of omega-3 fatty acids, which exhibit a unique mode of action. These substances activate an endogenous cardio-protective signaling pathway, providing both anti-arrhythmic effects and curative benefits by stabilizing heart rhythm and preventing electrical and structural remodeling of the heart. In addition to cardiovascular applications, OMEICOS also explores treatments for inflammatory and ophthalmic diseases, aiming to deliver safe and effective therapeutic options for various medical indications.

GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.

WeSustain develops and sells web-based software for enterprise sustainability management. The company’s ESM software is a management support system that helps companies go green and manage products, processes, and technologies in an environment-friendly manner. WeSustain’s ESM software enables the clients to establish a software-supported ESM solution, as well as manage, improve, and report their ESM performance on a global basis while mitigating sustainability risks. The company was founded in 2010 and is based in Buxtehude, Germany.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, founded in 2010. It specializes in developing innovative solutions for the treatment and management of glaucoma, a prevalent eye disease. The company's flagship product, Eyemate, is an implantable micro sensor designed for continuous intraocular pressure measurement. This biocompatible device allows for 24-hour monitoring without compromising the patient's vision or overall well-being. By integrating advanced medical technology with information technology, Implandata aims to enhance the efficiency of glaucoma therapy, benefiting patients, their families, and caregivers. The company's focus on addressing unmet needs in glaucoma care positions it as a significant player in the ophthalmic medical device sector.

AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

flinc AG, founded in 2010 and based in Ludwigshafen, Germany, operates a pioneering social mobility network application designed to facilitate real-time ridesharing by matching drivers and passengers. This innovative platform allows users to connect via desktop, smartphone, or navigation devices, ensuring a seamless experience for sharing everyday rides. By integrating navigation software, flinc enables drivers to reach passengers directly without the need for phone calls or text messages. The app's advanced route-matching algorithm can identify riders along the driver's route, calculate detours, and determine pricing. Users can select their match preferences, ranging from direct contacts to broader peer groups. Flinc also offers specialized solutions for companies and public transit organizations, promoting environmentally friendly commuting options. Its focus is primarily on short- to medium-length journeys, with integrated local transit schedules to enhance user convenience. As a subsidiary of moovel GmbH since 2017, flinc continues to develop its unique blend of technology, user experience design, and business development to advance urban mobility solutions.

Simplesurance GmbH is a Berlin-based company that specializes in developing cross-selling software solutions for e-commerce. Founded in 2012, it focuses on integrating insurance offerings directly into the online checkout process, allowing customers to purchase relevant insurance products alongside their purchases. This innovative approach enables online retailers to enhance their revenue by monetizing customers multiple times during a single transaction. Simplesurance serves over 2,000 partners, including prominent e-commerce platforms and electronic manufacturers, by providing flexible and effective cross-selling solutions. Additionally, the company offers a digital broker service that allows customers to manage their insurance policies conveniently from their smartphones, ensuring a paperless experience. With a commitment to blending traditional insurance with digital commerce, Simplesurance is positioned at the intersection of these two industries.

Capical GmbH specializes in the development and marketing of advanced electrocardiography (ECG) devices that utilize capacitive electrodes for contact-free patient monitoring. Founded in 2010 and based in Braunschweig, Germany, the company has established itself as a leader in capacitive sensor technology, which has applications beyond healthcare, including monitoring driver states in vehicles and physiological parameters in furniture such as chairs and beds. Capical's innovative approach allows for the continuous monitoring of heart and respiratory rates, cardiac arrhythmias, and other vital signs without direct skin contact, enhancing patient comfort and safety. The company also engages in extensive research and development to integrate its monitoring solutions into various products, supporting clients from initial prototyping to serial production. Capical has received several awards for its technological advancements and is recognized for its pioneering work in medically approved capacitive ECG devices, aiming to improve quality of life for elderly and ill individuals while also enhancing safety in automated driving scenarios.

miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with products from the fields of Health Style, Home & Living, Kitchen and fashion accessories.

Sirion Biotech specializes in viral vector technology, which is essential for delivering genetic material into cells and developing innovative therapeutics, such as gene therapy for cancer. Founded in 2007, the company has become a global leader in gene modification of mammalian cells, offering a range of viral vector types, including adenovirus, adeno-associated virus (AAV), and lentivirus, all available within weeks. Sirion Biotech supports both academic and industry sectors through various commercial arrangements, including fee-for-service and licensing agreements. The company has experienced significant growth, with an annual increase of 70% since its inception, and has successfully completed over 500 projects. With offices in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion Biotech is well-positioned to meet the needs of researchers and developers in the field of gene therapy. The company is privately held and actively seeks new investors to support its ongoing growth and technological advancements in the rapidly evolving biotechnology industry.

Orpheus GmbH, founded in 2005 by Dr. Joerg Dittrich and Michael Lauer, specializes in software solutions for spend and procurement performance management. Based in Nuremberg, Germany, with additional offices in Mainz and Cologne, the company offers a range of products, including SpendControl for procurement controlling and spending management, and InitiativeTracker for managing sourcing initiatives. Orpheus also provides data management solutions such as a data consolidation tool and DeltaClass for automated classification of invoices and orders. To enhance data security, the company offers the DataMaskingSuite. Additionally, Orpheus develops custom business intelligence solutions and provides consulting services in spend management and data management, assisting clients with system design, report implementation, and data validation. Its clientele includes small, medium, and large enterprises in Germany and internationally, with notable partnerships among innovative DAX and MDAX companies. As of February 2020, Orpheus operates as a subsidiary of McKinsey & Company, Inc.

ZooRoyal is an online platform that offers accessories and supplies for pet dogs, cats, reptiles, horses, fish, and more. Its operations are based in Würselen, Germany.

clickworker GmbH is a prominent provider of crowdsourcing solutions, offering a wide array of services in Germany and internationally. Established in 2005 and based in Essen, Germany, the company connects over 6 million freelancers, known as Clickworkers, who perform various tasks across 18 languages and more than 30 markets. clickworker specializes in areas such as web research, text creation, categorization and tagging, surveys, and mobile crowdsourcing. It breaks down complex projects into micro jobs, which are executed by qualified Clickworkers and then compiled into quality-assured results for clients. The company also offers a self-service marketplace for smaller tasks, enhancing accessibility for customers. With a focus on scalable solutions, clickworker aims to deliver efficient and cost-effective services, supporting businesses in areas like e-commerce data management and search engine optimization. The company was formerly known as humanGrid GmbH before rebranding in 2013.

RegioHelden GmbH, founded in 2010 and based in Stuttgart, Germany, specializes in online marketing services, particularly in search engine optimization and marketing. The company supports entrepreneurs, small businesses, and regional companies, helping them leverage the internet to enhance their visibility and reach potential customers. RegioHelden provides tools that enable local advertisers to connect with their online audience, convert leads into clients, and measure the effectiveness of their marketing campaigns. Since August 2015, it has operated as a subsidiary of Ströer SE.

avandeo, a Munich, Germany- and Shanghai, China-based startup that operates an online destination for designer furniture and home accessories.

Zalando, founded in 2008 and headquartered in Berlin, is Europe's largest online fashion platform, serving nearly 50 million active customers across 17 markets. The platform offers an extensive range of clothing, footwear, accessories, and beauty products from over 1,500 brands, including both internationally recognized names and local labels. With a strong focus on optimizing the online shopping experience, Zalando employs advanced technology and logistics solutions to enhance customer satisfaction. The company operates 12 fulfillment centers strategically located throughout Europe, allowing it to efficiently meet local customer needs. Zalando has established itself as a key player in the European online fashion market, holding approximately 12% of the market share in online apparel sales, with a significant presence in the DACH region, which includes Germany, Austria, and Switzerland. Its vision is to become the starting point for fashion, continuously innovating to inspire and engage customers.

Orpheus GmbH, founded in 2005 by Dr. Joerg Dittrich and Michael Lauer, specializes in software solutions for spend and procurement performance management. Based in Nuremberg, Germany, with additional offices in Mainz and Cologne, the company offers a range of products, including SpendControl for procurement controlling and spending management, and InitiativeTracker for managing sourcing initiatives. Orpheus also provides data management solutions such as a data consolidation tool and DeltaClass for automated classification of invoices and orders. To enhance data security, the company offers the DataMaskingSuite. Additionally, Orpheus develops custom business intelligence solutions and provides consulting services in spend management and data management, assisting clients with system design, report implementation, and data validation. Its clientele includes small, medium, and large enterprises in Germany and internationally, with notable partnerships among innovative DAX and MDAX companies. As of February 2020, Orpheus operates as a subsidiary of McKinsey & Company, Inc.

Evidanza is a software provider specializing in business intelligence solutions, headquartered in Salching, Germany. Founded in 2001, the company focuses on developing software that transforms complex data into relevant insights, facilitating informed decision-making for businesses. Its offerings include tools for reporting, planning, OLAP analysis, risk management, cost calculations, and compliance with IFRS and US GAAP standards. Evidanza's software aims to digitize and optimize various commercial processes, including accounting, cost accounting, customer relationship management, and corporate planning. By enhancing data management and organizational efficiency, the company helps clients improve cash flow, refine their cost structures, and develop robust business models.

Subitec GmbH, founded in 2000 as a spin-off from the Fraunhofer Institute for Interfacial and Biotechnology, specializes in manufacturing microalgae biotechnology cultivation equipment and turn-key production systems. The company offers a range of Flat Panel Airlift Photobioreactors in various sizes, including 6 liter, 28 liter, 100 liter, and 180 liter volumes, along with essential components such as lighting systems, media feeds, temperature control, and harvesting tools. Subitec's systems are designed for diverse applications, including nutraceuticals, food and feed, aquaculture, cosmetics, research, and energy markets. The company provides solutions for indoor, outdoor, compact, and hybrid systems, as well as pilot plants, enabling clients to produce sustainable bio-products from microalgae. Based in Stuttgart, Germany, Subitec operates as a subsidiary of Roeser Medical GmbH & Co. KG.

Algiax Pharmaceuticals GmbH is a biotechnology company based in Erkrath, Germany, founded in April 2011. The company specializes in the discovery and development of innovative products aimed at treating nervous system diseases and dysfunctions, with a particular emphasis on neuropathic pain and spinal cord injuries. Algiax Pharmaceuticals develops molecules that inhibit the enzyme dehydroorotate dehydrogenase, addressing central nervous system disorders associated with chronic pain. The company has demonstrated financial stability, having raised 4.3 million Euros in Series A financing from a consortium of private and state-backed investors. Algiax Pharmaceuticals is committed to addressing significant unmet medical needs in the field of neurology.

Micropelt started as a project of Infineon Technologies AG in cooperation with the Fraunhofer Institute for Physical Measurement Techniques (Fraunhofer IPM) in Freiburg (Germany). Now it is a StartUp which is funded by SHS, MBG, KfW Mittelstandsbank, L-Bank and IBG. Their team develops thin film thermoelectric components based on semiconductor manufacturing processes.

Simplesurance GmbH is a Berlin-based company that specializes in developing cross-selling software solutions for e-commerce. Founded in 2012, it focuses on integrating insurance offerings directly into the online checkout process, allowing customers to purchase relevant insurance products alongside their purchases. This innovative approach enables online retailers to enhance their revenue by monetizing customers multiple times during a single transaction. Simplesurance serves over 2,000 partners, including prominent e-commerce platforms and electronic manufacturers, by providing flexible and effective cross-selling solutions. Additionally, the company offers a digital broker service that allows customers to manage their insurance policies conveniently from their smartphones, ensuring a paperless experience. With a commitment to blending traditional insurance with digital commerce, Simplesurance is positioned at the intersection of these two industries.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

In 2009 founders Niclaus Mewes and Sven Kuelper launched "mytaxi" - the first taxi app with a direct connection between passenger and driver. mytaxi has grown to the fastest growing taxi-app with more than 7 million downloads and 35.000 connected taxis. mytaxi is available in over 40 German cities as well as Washington, Madrid, Barcelona, Warsaw, Vienna, Graz, Salzburg and Zurich. Investors include T-Venture Holding GmbH (Deutsche Telekom AG), Daimler Mobility Services GmbH (Daimler AG), KfW, e42 GmbH and Lars Hinrichs (Cinco Capital GmbH). mytaxi brings a demand for quality to the taxi service for the first time. Every driver using mytaxi has the ability to become a contractor and build their own client base by consistently providing passengers with good service and earning high customer ratings. Through the given peer-to-peer connection between passenger and driver the whole ordering process becomes very transparent for both. The passenger can not only track the taxi’s arrival in the app but also see which driver is coming. For the driver the cost modell is very attractive as they only pay for a successfully completed trip. The aim of mytaxi is to drive the concept of urban mobility and to further strengthen its position as an international leader in this field. Accordingly to that mytaxi took over the app development services for Daimler Mobility Services GmbH (Daimler AG).

Sividon Diagnostics GmbH, founded in 2011 and based in Cologne, Germany, specializes in developing treatment-related diagnostic tests, particularly in the field of molecular tumor diagnostics. The company offers a portfolio that includes the ImmunoPredict biomarker test and the EndoPredict kit, an RNA expression test that evaluates the aggressiveness of breast cancer by analyzing 12 genes at a molecular level. As a management buyout from Siemens Healthcare Diagnostics, Sividon aims to enhance the quality of companion diagnostics in oncology, thereby enabling more individualized and evidence-based treatment decisions for cancer patients. The company benefits from the expertise of its team of experienced scientists and managers, as well as from a network of international experts in molecular diagnostics. Sividon operates as a subsidiary of Myriad Services GmbH.

Pay by Shopping is an innovative tool that can be used to reach new customers, increase website traffic, and to raise conversion rates. Available on browser games, via Mobile, and as a Facebook-App, Pay by Shopping enables users to earn virtual currency and items, such as rebates, from a Publisher by shopping at an Advertiser. It drives incremental revenue for Publishers while at the same time serving as a performance marketing tool for online Advertisers. Advertisers gain new customers and see increased sales. Current partnerships include Facebook, OTTO, Zalando, Ubisoft, and Bigpoint. Pay by Shopping is a product of deal united GmbH. The firm is based in Munich with offices in Paris and San Francisco.

Sirion Biotech specializes in viral vector technology, which is essential for delivering genetic material into cells and developing innovative therapeutics, such as gene therapy for cancer. Founded in 2007, the company has become a global leader in gene modification of mammalian cells, offering a range of viral vector types, including adenovirus, adeno-associated virus (AAV), and lentivirus, all available within weeks. Sirion Biotech supports both academic and industry sectors through various commercial arrangements, including fee-for-service and licensing agreements. The company has experienced significant growth, with an annual increase of 70% since its inception, and has successfully completed over 500 projects. With offices in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion Biotech is well-positioned to meet the needs of researchers and developers in the field of gene therapy. The company is privately held and actively seeks new investors to support its ongoing growth and technological advancements in the rapidly evolving biotechnology industry.

Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters specifically designed for the treatment of heart diseases, with a primary focus on atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. Additionally, Vimecon provides advisory services to various clients in both academic and industrial research and development. Its innovations aim to enhance healthcare outcomes and support advancements in the treatment of cardiovascular diseases and cardiac arrhythmias.

CYNORA GmbH, founded in 2008 and headquartered in Bruchsal, Germany, specializes in the development and manufacture of organic electronics, particularly organic light-emitting diodes (OLEDs). The company focuses on creating highly efficient blue and green emitter systems utilizing Thermally Activated Delayed Fluorescence (TADF) technology. This innovative approach allows for the conversion of triplet excitons into light, thereby enhancing power efficiency and reducing electrical stress within OLED devices. As demand for thin, flexible screens with improved image quality and lower power consumption rises, CYNORA aims to provide added value to OLED producers with its iridium-free, purely organic emitter solutions. By addressing the challenges faced in developing stable and efficient blue emitters, CYNORA is positioned to support advancements in the AMOLED market and contribute to the evolution of display technology.

OctreoPharm Sciences GmbH is a biopharmaceutical company based in Berlin, Germany, specializing in the development of radiopharmaceuticals aimed at the diagnosis and treatment of neuroendocrine tumors. Founded in 2010, the company is engaged in creating theranostic antagonistic peptides that serve both diagnostic and therapeutic purposes. Its notable products include OPS201, designed for selective internal peptide receptor radionuclide therapy using radioisotopes like 90Y or 177Lu, and OPS202, which is a gallium-68 labeled somatostatin receptor antagonist intended for positron emission tomography. As of mid-2015, OctreoPharm Sciences operates as a subsidiary of Ipsen S.A.

clickworker GmbH is a prominent provider of crowdsourcing solutions, offering a wide array of services in Germany and internationally. Established in 2005 and based in Essen, Germany, the company connects over 6 million freelancers, known as Clickworkers, who perform various tasks across 18 languages and more than 30 markets. clickworker specializes in areas such as web research, text creation, categorization and tagging, surveys, and mobile crowdsourcing. It breaks down complex projects into micro jobs, which are executed by qualified Clickworkers and then compiled into quality-assured results for clients. The company also offers a self-service marketplace for smaller tasks, enhancing accessibility for customers. With a focus on scalable solutions, clickworker aims to deliver efficient and cost-effective services, supporting businesses in areas like e-commerce data management and search engine optimization. The company was formerly known as humanGrid GmbH before rebranding in 2013.

SAW Instruments specializes in the development, manufacture, and distribution of analytical systems designed for the life sciences sector. The company's innovative equipment enables label-free analysis of biomolecular interactions, offering a combination of high sensitivity, stability, and user-friendliness. SAW Instruments' products are utilized by leading research institutions in Germany and Switzerland, reflecting their effectiveness and reliability in advanced scientific research.

FAIRRANK GmbH is a digital marketing agency based in Cologne, Germany, specializing in search engine optimization and marketing services for small and medium-sized businesses. Founded in 2004, the company offers a range of services, including assessments of existing web presence, recommendations for improvement, and strategies to enhance visitor engagement on websites. Their offerings encompass search engine marketing, social media marketing, content marketing, web development, and usability optimization. FAIRRANK operates through a network of sales representatives, serving clients across various industries in Germany, Austria, and Switzerland. Since February 2015, FAIRRANK has been a subsidiary of Euro Serve Media GmbH, further extending its capabilities in the digital marketing landscape.

GILUPI GmbH is a medical device company based in Potsdam, Germany, specializing in the development and production of diagnostic products for the in vivo isolation of rare cells from circulating blood. The company's devices are specifically designed to isolate tumor cells by utilizing antibodies bound to a nano-detector, allowing for precise identification of circulating tumor cells. This technology enables healthcare professionals to perform in vivo isolation, supporting tailored therapeutic approaches for patients. GILUPI's products are CE certified, ensuring compliance with European health standards.

Based in Cologne, Germany, BLUE LION mobile GmbH is a tech startup that offers new types of communication and entertainment for the mobile phone. BLUE LION Mobile produces and distributes the mobile social-networking application and multiplayer gaming platform "qeep." Founded in 2006, the team is led by Cornelius Rost, Arefin Bashar Arif and Christian R. Schulte, who teamed up to head this venture after years of experience in the industries of telecommunications and hand-held devices.

Zimory GmbH specializes in carrier-grade cloud infrastructure management software tailored for cloud service providers, enterprises, and cloud brokers. Founded in 2007 and headquartered in Berlin, the company offers an intelligent Cloud Suite that simplifies, automates, and accelerates the creation, launch, and management of various cloud environments, including public, private, virtual private, and hybrid setups. Zimory's software enables the development of cloud marketplaces for enterprise services, applications, and infrastructure, allowing users to effectively leverage cloud computing's power and flexibility. Additionally, the company provides consulting, technical support services, and cloud management installations, serving global telecommunications carriers and government entities. Zimory has development centers in Erfurt, Germany, and Minsk, Belarus, as well as a subsidiary office in New York City. As of September 2016, Zimory GmbH is in liquidation.

VIOSO GmbH, founded in 2007 and based in Düsseldorf, Germany, specializes in automatic digital edge-blending and geometry alignment solutions for various visual applications worldwide. The company's offerings include VIOSO Player, a professional video playback software designed for mapping content on custom surfaces such as fulldome displays and 3D objects. Additional products include VIOSO Anyblend, an embedded solution for simulators and signage; VIOSO Anyblend VR & SIM for military and non-commercial applications; and Wings VIOSO, a media server tailored for large venues and events. VIOSO also provides high-resolution display technology through the VIOSO Blackbox 4K and auto-alignment solutions for video walls and digital signage. The company continues to innovate with customized projects and training services, all aimed at enhancing presentations and visual experiences. VIOSO's journey began with the "smartprojector" concept at Bauhaus University in Weimar, evolving into a comprehensive software suite that redefines how information is presented.

Phenex Pharmaceuticals AG is a drug discovery and development company founded in 2002 and headquartered in Ludwigshafen, Germany, with additional laboratories and offices in Heidelberg. The company specializes in small-molecule drug discovery, focusing on nuclear receptors to address various disease areas, including liver diseases, intestinal diseases, and cancer. Current research includes developing RORγt inverse agonists for autoimmune diseases and FXR agonists for non-alcoholic steatohepatitis. Phenex is dedicated to not only creating therapeutics for established targets but also identifying novel molecular mechanisms, which has led to the development of proprietary therapeutic small molecules. The company operates within the Biotech Cluster Rhine-Neckar, leveraging its expertise in biology and chemistry to advance innovative treatment options.

GreenPocket GmbH, founded in 2009 and based in Cologne, Germany, specializes in energy management software designed for utility companies. The company provides solutions for interpreting and visualizing smart metering data, including a household customer portal and energy management software tailored for commercial clients. Their offerings encompass various tools such as a web portal for real-time energy consumption visualization, a business customer portal for cost-saving comparisons, and smart home solutions that optimize the control of household appliances. By leveraging innovative technologies like artificial intelligence and data science, GreenPocket aims to create significant value from smart meter data, thereby supporting energy suppliers and corporate customers in the transition towards a more sustainable energy future. With experience in over 125 projects across 12 countries, GreenPocket is positioned as a trusted partner in the digitalization of the energy industry.

Locr GmbH is a company based in Braunschweig, Germany, that specializes in geo-based services and photo sharing. Established in 2006, Locr offers a platform known as locrExplorer, which allows users to browse and tag photos with location information through geotagging. This service visualizes locations on street maps and satellite images, providing insights about the photographed subjects and their surroundings. Additionally, Locr focuses on geo photography and geo-related print products, alongside providing software solutions for geotagging. The company also serves marketers by transforming data from geodata sources like OpenStreetMap into personalized maps and geo-information services, which help enhance mailing lists and improve engagement and response rates in marketing communications.

Galantos Pharma GmbH is a biotechnology company focused on developing drugs for the treatment of Alzheimer's disease and other neurodegenerative disorders. The company is advancing Memogain, an investigational pro-drug derived from galantamine, which aims to provide symptomatic relief and potential disease modification for patients with mild-to-moderate Alzheimer’s dementia. In addition to its drug development efforts, Galantos Pharma has established a technology platform for the screening and preclinical validation of drug candidates that target cholinergic and other neuro-receptors as well as various brain enzymes. Founded in 2005, the company is headquartered in Mainz, Germany.

clickworker GmbH is a prominent provider of crowdsourcing solutions, offering a wide array of services in Germany and internationally. Established in 2005 and based in Essen, Germany, the company connects over 6 million freelancers, known as Clickworkers, who perform various tasks across 18 languages and more than 30 markets. clickworker specializes in areas such as web research, text creation, categorization and tagging, surveys, and mobile crowdsourcing. It breaks down complex projects into micro jobs, which are executed by qualified Clickworkers and then compiled into quality-assured results for clients. The company also offers a self-service marketplace for smaller tasks, enhancing accessibility for customers. With a focus on scalable solutions, clickworker aims to deliver efficient and cost-effective services, supporting businesses in areas like e-commerce data management and search engine optimization. The company was formerly known as humanGrid GmbH before rebranding in 2013.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

Elara Pharmaceuticals Gmbh provides research and pharmaceutical development services for new anti-cancer drugs. In addition Elara Pharmaceuticals Gmbh has discovered lead series of small, bioactive molecules that have anti-tumour activity, based on inhibitors of estrogen signaling and Aurora kinases. Elara Pharmaceuticals Gmbh was founded in 2006 and is based in Heidelberg, Germany.

Nevigo GmbH develops multi-platform game engine for video games. The company offers storytelling games, compositing methods, grading system, and camera system with its platform. Nevigo GmbH is based in Bochum, Germany.

Stream5 is a German video streaming company.

CorporateWorld GmbH operates a credit card based on-line travel management system for business travellers. It also offers travel management services. The company is based in Munich, Germany.

Metasonic AG is a Germany-based IT company founded in 2004 by Albert Fleischmann, specializing in enterprise software design and development. The company offers the Metasonic Suite, a platform for subject-oriented business process management that facilitates dynamic process applications and enhances communication among various business participants. In addition to its software solutions, Metasonic provides a variety of training courses focused on business process management and the Metasonic Suite tools, including standard trainings, certifications, and introductory sessions on the S-BPM methodology. The company collaborates with several international partners, such as Alius Consulting Services and Devoteam, to expand its reach and enhance its offerings.

Novaled AG is a technology provider specializing in organic light-emitting diode (OLED) technologies, targeting the organic electronics market. Based in Dresden, Germany, and established in 2003, the company focuses on high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers complete solutions that include its proprietary Doping technology and materials, catering to customers in various sectors, including televisions and mobile devices. The company has built strong partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled maintains branch offices in Asia to support its global operations.

OXID eSales AG, headquartered in Freiburg, Germany, specializes in multi-channel e-commerce solutions, offering open source shopping cart software known as OXID eShop. Founded in 2003, the company serves both business-to-business (B2B) and business-to-consumer (B2C) markets, providing scalable and customizable e-commerce platforms. Major clients such as Lekkerland, Strenesse, Intersport, Gravis, and Deutsche Post utilize OXID's solutions for their online operations. The platform is designed for flexibility and rapid deployment, supported by a network of over 100 certified solution partners. OXID eShop integrates with the OXID eFire intelligence platform, which facilitates cloud-based e-commerce management, including online marketing, payment services, and intelligent search functionalities. This commercial open source software approach ensures high-quality development and long-term investment security for users, making it a valuable choice for medium-sized companies seeking to enhance their digital sales processes.

VIOSO GmbH, founded in 2007 and based in Düsseldorf, Germany, specializes in automatic digital edge-blending and geometry alignment solutions for various visual applications worldwide. The company's offerings include VIOSO Player, a professional video playback software designed for mapping content on custom surfaces such as fulldome displays and 3D objects. Additional products include VIOSO Anyblend, an embedded solution for simulators and signage; VIOSO Anyblend VR & SIM for military and non-commercial applications; and Wings VIOSO, a media server tailored for large venues and events. VIOSO also provides high-resolution display technology through the VIOSO Blackbox 4K and auto-alignment solutions for video walls and digital signage. The company continues to innovate with customized projects and training services, all aimed at enhancing presentations and visual experiences. VIOSO's journey began with the "smartprojector" concept at Bauhaus University in Weimar, evolving into a comprehensive software suite that redefines how information is presented.

Ubitexx GmbH develops and distributes management and security software for smartphones and mobile devices. It offers ubi-Suite, a centralized smartphone management suite of capabilities. The company also provides strategic mobile management consulting, training and installation, and technical support services. It serves banking, insurance, pharmaceuticals, energy, media, engineering, and automotive industries, as well as public sector. Ubitexx GmbH was founded in 2002 and is based in Munich, Germany with an additional office in Cambridge, Massachusetts.

Phenex Pharmaceuticals AG is a drug discovery and development company founded in 2002 and headquartered in Ludwigshafen, Germany, with additional laboratories and offices in Heidelberg. The company specializes in small-molecule drug discovery, focusing on nuclear receptors to address various disease areas, including liver diseases, intestinal diseases, and cancer. Current research includes developing RORγt inverse agonists for autoimmune diseases and FXR agonists for non-alcoholic steatohepatitis. Phenex is dedicated to not only creating therapeutics for established targets but also identifying novel molecular mechanisms, which has led to the development of proprietary therapeutic small molecules. The company operates within the Biotech Cluster Rhine-Neckar, leveraging its expertise in biology and chemistry to advance innovative treatment options.

QuinLogic is a German company specializing in quality assurance software for steel and aluminum mills, aimed at enhancing industrial mass production while maintaining high flexibility. By leveraging advanced computing power and storage capabilities, QuinLogic has created user-friendly software solutions that are currently operational in numerous high-end flat rolling mills worldwide. The software ensures consistent quality of slabs, plates, and coils, catering to demanding sectors such as automotive, aerospace, wind energy, and materials requiring high strength and wear resistance. Additionally, QuinLogic's software provides proactive support to address production issues promptly, thereby reducing deficiencies in customer products. Its seamless integration with existing manufacturing execution systems (MES), enterprise resource planning (ERP), and gauging systems enables comprehensive functionality across both current and new production lines.

Biontis GmbH specializes in developing automated processes for the biochemical analysis of complex liquid mixtures and manufactures a range of laboratory equipment. Founded in 2002 and based in Geesthacht, Germany, the company provides essential tools for laboratories involved in water analysis, food inspections, forensic medicine, and clinical diagnostics. Biontis offers a comprehensive array of products, including analytical procedures, test kits, SPE columns, reagents, and automation devices, all designed to facilitate efficient and innovative analytical processes. By streamlining treatment steps such as evaporation, heating, and dissolution, Biontis enables researchers to conduct more effective and cost-efficient analyses. The company's products are marketed primarily in Germany.

Locr GmbH is a company based in Braunschweig, Germany, that specializes in geo-based services and photo sharing. Established in 2006, Locr offers a platform known as locrExplorer, which allows users to browse and tag photos with location information through geotagging. This service visualizes locations on street maps and satellite images, providing insights about the photographed subjects and their surroundings. Additionally, Locr focuses on geo photography and geo-related print products, alongside providing software solutions for geotagging. The company also serves marketers by transforming data from geodata sources like OpenStreetMap into personalized maps and geo-information services, which help enhance mailing lists and improve engagement and response rates in marketing communications.

DIVOLUTION is a German company that offers testing and targeting technology.

Galantos Pharma GmbH is a biotechnology company focused on developing drugs for the treatment of Alzheimer's disease and other neurodegenerative disorders. The company is advancing Memogain, an investigational pro-drug derived from galantamine, which aims to provide symptomatic relief and potential disease modification for patients with mild-to-moderate Alzheimer’s dementia. In addition to its drug development efforts, Galantos Pharma has established a technology platform for the screening and preclinical validation of drug candidates that target cholinergic and other neuro-receptors as well as various brain enzymes. Founded in 2005, the company is headquartered in Mainz, Germany.

KINAXO Biotechnologies is a privately-held biotechnology company based in Munich/Martinsried, Germany. They are a service company specializing in chemical proteomics methods to support the successful development of small molecule drugs. As a spin-off of the Max Planck Institute of Biochemistry in Martinsried, they continuously expand and improve their technology platform in collaboration with the leading Max Planck laboratories of Axel Ullrich, Henrik Daub and Matthias Mann. KINAXO offers its clients extensive experience in cellular target profiling and other chemical proteomics applications.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

t2cure GmbH is a biopharmaceutical company based in Frankfurt am Main, Germany, focused on developing progenitor cell-based regenerative therapeutics for cardiovascular diseases. Founded in 2006, the company specializes in providing autologous bone marrow-derived progenitor cells as treatments for conditions such as ischemic heart diseases, non-ischemic heart failure, peripheral arterial occlusive disease, and diabetic polyneuropathy. t2cure's innovative therapeutics aim to enhance recovery by improving blood flow and promoting tissue repair through the release of regenerative messenger substances. By harnessing the potential of mononuclear cells obtained from patients' bone marrow, t2cure seeks to offer new treatment options for individuals suffering from various cardiovascular ailments.

NanoCompound GmbH engages in the development, production, application, and sale of multifunctional nanocompounds, and structured nanoscale carbon-fullerene with diamond core. It offers nanoparticle systems and their combined applications. The company was founded in 2004 and is based in Baesweiler, Germany. NanoCompound GmbH operates as a subsidiary of NanoCompound Holding AG.

Innolume GmbH is a manufacturer of advanced laser diodes based in Dortmund, Germany. Established in 2002, the company specializes in a wide array of optoelectronic devices, including single-mode and broad-area laser diodes, comb-lasers, and semiconductor optical amplifiers. Innolume's products are designed for various applications, such as Raman amplification, optical interconnects, and medical and industrial uses. Notably, the company has developed a novel comb laser light engine that facilitates economical wavelength-division multiplexing for short-reach optical connections in computing environments. This innovation enhances efficiency by reducing the need for multiple lasers and underutilized fiber, significantly lowering costs and power consumption. Innolume has also received recognition for its temperature-independent distributed feedback laser, which has the potential to impact the future of data communication.

Micropelt started as a project of Infineon Technologies AG in cooperation with the Fraunhofer Institute for Physical Measurement Techniques (Fraunhofer IPM) in Freiburg (Germany). Now it is a StartUp which is funded by SHS, MBG, KfW Mittelstandsbank, L-Bank and IBG. Their team develops thin film thermoelectric components based on semiconductor manufacturing processes.

VERTILAS GmbH, founded in 2001 and headquartered in Garching, Germany, specializes in the development, production, and distribution of long-wavelength vertical cavity surface emitting laser diodes (VCSELs) for applications in optical communications technology, sensor engineering, and measurement methods. The company offers products for gas sensing and parallel optics, positioning itself as a leading provider in the long-wavelength VCSEL market with laser diodes that operate within a wavelength range of 1.3 µm to 2 µm. Additionally, VERTILAS provides engineering services related to fiber optics, semiconductors, and laser diodes, as well as computer programming tailored for semiconductor manufacturing processes.

Phenex Pharmaceuticals AG is a drug discovery and development company founded in 2002 and headquartered in Ludwigshafen, Germany, with additional laboratories and offices in Heidelberg. The company specializes in small-molecule drug discovery, focusing on nuclear receptors to address various disease areas, including liver diseases, intestinal diseases, and cancer. Current research includes developing RORγt inverse agonists for autoimmune diseases and FXR agonists for non-alcoholic steatohepatitis. Phenex is dedicated to not only creating therapeutics for established targets but also identifying novel molecular mechanisms, which has led to the development of proprietary therapeutic small molecules. The company operates within the Biotech Cluster Rhine-Neckar, leveraging its expertise in biology and chemistry to advance innovative treatment options.